Cytokine-Induced Killer Cell Immunotherapy Combined With Gemcitabine Reduces Systemic Metastasis in Pancreatic Cancer: An Analysis Using Preclinical Adjuvant Therapy-Mimicking Pancreatic Cancer Xenograft Model.
Jin Ho ChoiGun He NamJun-Man HongIn Rae ChoWoo Hyun PaikJi Kon RyuYong-Tae KimSang Hyub LeePublished in: Pancreas (2023)
The combination of CIK and gemcitabine suppressed systemic metastatic recurrence, with promising efficacy and good tolerability in an adjuvant setting of pancreatic cancer.